Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports | Ctech
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Prosecutors Sue Teva's U.S. Business Over Charitable Donations - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva charged in US price-fixing investigation | Financial Times
Teva shares surge after announcing global opioid settlement
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva seeks CEO replacement as Shultz will retire in 2023: WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva shares surge after announcing global opioid settlement
